Innovative, long-acting treatments – for patients and society
Camurus is committed to improving the lives of patients with severe and chronic diseases
Learn moreUpdates
Latest news
Disease areas
Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care.
Events
Upcoming events
-
05Nov
Interim Report January-September 2026
The interim report January-September is published at 7.00 am CET on 5 November 2026.
-
05Nov
Interim Report January-September 2026 – Webcast
Financial analysts, investors and media are invited to attend a webcast and presentation of the results at 2:00 pm CEST.
Access the webcast using this link: Webcast
To participate in the presentation and ask questions, please register using the link below. After registering, please use the provided phone number and conference ID to dial in. Register to dial in
-
09Nov
BIO Europe 2026
Camurus will participate in this conference in Cologne, Germany, 9-11 November, 2026.
Latest financial report
Camurus’ Interim Report Second Quarter 2026
15 July 2026
Annual Report 2025
Pipeline
Diversified pipeline with large potential
Camurus’ innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
Sustainability
Our approach to sustainability
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders.
